Watch Knowledge Forum On-Demand About the Knowledge Forum Are you seeking meaningful scientific innovation to support quality data for your schizophrenia trial? Watch this special Knowledge Forum to gain scientific perspectives from pioneers in the Central Nervous System trial world and experts in clinical endpoint solutions: In a decentralizing, peri-pandemic trial world, schizophrenia research has […]
What better way to assess a person’s ability to perform the activities of daily living than to ask them to actually perform those activities? The challenge, of course, is doing that in a controlled, scientifically validated environment. WCG’s Virtual Reality Functional Capacity Assessment Tool (VRFCAT) allows clinicians and researchers to do just that: It assesses […]
About the Webinar We’ve seen significant advances in the use of artificial intelligence (AI) and machine learning computer applications to aid and augment the field of radiology. What is the status of the technology today? How does it receive FDA clearance? In radiology, artificial intelligence applications often require conducting multi-reader multi-case (MRMC) studies on their […]
Choosing Between Provisioned, BYOD, and Hybrid Models for ePRO: Which Is Right for Your Clinical Trial?
As more and more trials opt to include electronic patient reported outcomes (ePRO), sponsors must consider whether they will provision devices or use a bring-your-own-device (BYOD) model. In some cases, they may choose a hybrid option that allows some participants to use BYOD and others to receive provisioned devices. This article explores some key factors […]
Like clinical trials in adult populations, pediatric clinical trials increasingly incorporate electronic patient-reported outcome (ePRO) systems to gather data directly from patients. One challenge unique to pediatric trials is that many trials also seek to gather information from one or more caregivers, known as informants. The chosen informant is often a parent, but depending on […]
Recent Innovations and their Regulatory Implications for Multiple Sclerosis Trials Addressed in a Special Issue of the Journal of Clinical Neurophysiology by VeraSci Experts
This week, the Journal of Clinical Neurophysiology published a special issue about recent innovations and their regulatory implications for clinical trials in multiple sclerosis. Dr. Mark Skeen, Senior Medical Scientist at VeraSci and Professor of Neurology at Duke University Medical Center served as a guest editor and contributor for the issue. The issue includes the article “Biomarkers and Surrogate […]